Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer
NCT07511894
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
33
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Experimental Group
Sponsor
Nanfang Hospital, Southern Medical University